Personalized Antiplatelet Therapy in CAD Patients

CompletedOBSERVATIONAL
Enrollment

15,000

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

October 31, 2021

Conditions
Coronary Artery Disease
All Listed Sponsors
lead

Xinjiang Medical University

OTHER

NCT05174143 - Personalized Antiplatelet Therapy in CAD Patients | Biotech Hunter | Biotech Hunter